This country profile provides an overview of Mali’s progress in reaching those in need of mass NTD treatment based on 2017 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Download country profiles

Treatment coverage

Elephantiasis
74%
Blinding trachoma
100%
Intestinal worms
100%
Bilharzia
100%
River blindness
78%
6.5 million people received treatment in Mali in 2017 0.34 million people did not receive treatment in Mali in 2017

Priorities for progress in Mali

  • Mali has a well implemented and consistent preventive chemotherapy programme for NTDs.
  • It is encouraged to work to maintain the annual implementation of all components, in all risk groups.
  • Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.

Elephantiasis

Treatment coverage increased from 69% in 2016 to 74% in 2017.

People needing treatment
2.34m
People receiving treatment
1.73m

Blinding trachoma

Treatment coverage increased from 1% in 2016 to 100% in 2017.

People needing treatment
Surveillance
People receiving treatment
Not applicable

Intestinal worms

Treatment coverage maintained at 100% from 2016 to 2017.

Pre-sch and school-aged children needing treatment
Surveillance
Pre-school and school-aged children receiving treatment
Not applicable

Bilharzia

Treatment coverage maintained at 100% from 2016 to 2017.

School-aged children needing treatment
2.93m
School-aged children receiving treatment
2.93m

River blindness

Treatment coverage slightly increased from 72% in 2016 to 78% in 2017.

People needing treatment
5.74m
People receiving treatment
4.47m

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Mali.